Posted in | News | Military Robotics

Lockheed Martin Receives $11M Contract to Develop Autonomous Mobility Appliqué System

Lockheed Martin received an $11 million contract for the development, integration and testing of the Autonomous Mobility Applique System (AMAS).

Work on the contract, which was awarded by the Department of Defense through its Other Transaction Agreement with the Robotics Technology Consortium, will be performed in Littleton, Colo., and Dallas through 2014.

The multiplatform kit integrates low-cost sensors and control systems onto U.S. Army and Marine Corps tactical vehicles to assist drivers or enable autonomous operation in convoys. AMAS does not interfere with drivers who choose to operate their vehicle manually. It adds a sensing and control function that alerts users so they can rapidly react to safety threats.

"Driving tactical vehicles in a combat zone can be dangerous, but AMAS will help by giving drivers an automated option to alert, stop and adjust, or take full control under user supervision," said Scott Greene, vice president of ground vehicles in Lockheed Martin's Missiles and Fire Control business. "We pioneered this technology and have logged more than 16,000 miles with it on several platforms. AMAS is a concrete step in using autonomous systems to let soldiers be soldiers instead of being drivers."

Lockheed Martin proved much of the AMAS technology as part of the award-winning Convoy Active Safety Technology (CAST) program, which applied advanced leader/follower autonomy to multiple tactical vehicle types that serve in convoys. From the beginning, the kit was designed to be low-cost and essentially platform independent. The system has a simple, single-button activation, and soldiers were using the system with as little as an hour's training.

The U.S. Army Tank-Automotive Research, Development and Engineering Center (TARDEC) tested the CAST vehicles under a variety of combat conditions and demonstrated that the system will save lives by improving both safety and security.

"This technology is extremely versatile, considering our robust perception and control algorithms and our low-cost sensor suite," said Greene. "We are confident we can spread its use across the eight vehicle types the program will use for demonstration. Many of the algorithms on AMAS also control Lockheed Martin's Squad Mission Support System unmanned ground vehicle, which was recently used by soldiers in Afghanistan."

The Robotics Technology Consortium is a non-profit industry organization formed in 2008 to speed the creation and deployment of ground robotics technology for the Defense Department and other government organizations. The consortium develops solutions to meet critical needs identified by the Office of the Secretary of Defense Joint Ground Robotics Enterprise to support national security objectives.

Source: http://www.lockheedmartin.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Lockheed Martin Corporation. (2019, February 20). Lockheed Martin Receives $11M Contract to Develop Autonomous Mobility Appliqué System. AZoRobotics. Retrieved on April 26, 2024 from https://www.azorobotics.com/News.aspx?newsID=3358.

  • MLA

    Lockheed Martin Corporation. "Lockheed Martin Receives $11M Contract to Develop Autonomous Mobility Appliqué System". AZoRobotics. 26 April 2024. <https://www.azorobotics.com/News.aspx?newsID=3358>.

  • Chicago

    Lockheed Martin Corporation. "Lockheed Martin Receives $11M Contract to Develop Autonomous Mobility Appliqué System". AZoRobotics. https://www.azorobotics.com/News.aspx?newsID=3358. (accessed April 26, 2024).

  • Harvard

    Lockheed Martin Corporation. 2019. Lockheed Martin Receives $11M Contract to Develop Autonomous Mobility Appliqué System. AZoRobotics, viewed 26 April 2024, https://www.azorobotics.com/News.aspx?newsID=3358.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.